This company is no longer active
CHRC Stock Overview
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Chr. Hansen Holding A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 554.20 |
| 52 Week High | DKK 559.10 |
| 52 Week Low | DKK 470.65 |
| Beta | 0.33 |
| 1 Month Change | 1.50% |
| 3 Month Change | n/a |
| 1 Year Change | 8.16% |
| 3 Year Change | -1.96% |
| 5 Year Change | -13.30% |
| Change since IPO | 251.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| CHRC | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0.1% | -2.6% | -2.6% |
| 1Y | 8.2% | -25.9% | 2.4% |
Return vs Industry: CHRC exceeded the UK Chemicals industry which returned -44% over the past year.
Return vs Market: CHRC exceeded the UK Market which returned -5.1% over the past year.
Price Volatility
| CHRC volatility | |
|---|---|
| CHRC Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CHRC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CHRC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1843 | 3,834 | Mauricio Graber | www.chr-hansen.com |
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry.
Chr. Hansen Holding A/S Fundamentals Summary
| CHRC fundamental statistics | |
|---|---|
| Market cap | DKK 72.33b |
| Earnings (TTM) | DKK 1.69b |
| Revenue (TTM) | DKK 9.94b |
42.8x
P/E Ratio7.3x
P/S RatioIs CHRC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHRC income statement (TTM) | |
|---|---|
| Revenue | €1.33b |
| Cost of Revenue | €611.10m |
| Gross Profit | €723.30m |
| Other Expenses | €496.30m |
| Earnings | €227.00m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
Apr 04, 2024
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 54.20% |
| Net Profit Margin | 17.01% |
| Debt/Equity Ratio | 52.0% |
How did CHRC perform over the long term?
See historical performance and comparisonDividends
1.4%
Current Dividend Yield60%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/02/01 13:09 |
| End of Day Share Price | 2024/01/30 00:00 |
| Earnings | 2023/08/31 |
| Annual Earnings | 2023/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chr. Hansen Holding A/S is covered by 29 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Vitfell-Rasmussen | ABG Sundal Collier |
| Alexander Sloane | Barclays |
| James Targett | Berenberg |